Wang R, Doolan D L, Charoenvit Y, Hedstrom R C, Gardner M J, Hobart P, Tine J, Sedegah M, Fallarme V, Sacci J B, Kaur M, Klinman D M, Hoffman S L, Weiss W R
Malaria Program, Naval Medical Research Institute, Bethesda, Maryland 20889, USA.
Infect Immun. 1998 Sep;66(9):4193-202. doi: 10.1128/IAI.66.9.4193-4202.1998.
CD8(+) T cells have been implicated as critical effector cells in protective immunity against malaria parasites developing within hepatocytes. A vaccine that protects against malaria by inducing CD8(+) T cells will probably have to include multiple epitopes on the same protein or different proteins, because of parasite polymorphism and genetic restriction of T-cell responses. To determine if CD8(+) T-cell responses against multiple P. falciparum proteins can be induced in primates by immunization with plasmid DNA, rhesus monkeys were immunized intramuscularly with a mixture of DNA plasmids encoding four P. falciparum proteins or with individual plasmids. All six monkeys immunized with PfCSP DNA, seven of nine immunized with PfSSP2 DNA, and five of six immunized with PfExp-1 or PfLSA-1 DNA had detectable antigen-specific cytotoxic T lymphocytes (CTL) after in vitro restimulation of peripheral blood mononuclear cells. CTL activity was genetically restricted and dependent on CD8(+) T cells. By providing the first evidence for primates that immunization with a mixture of DNA plasmids induces CD8(+) T-cell responses against all the components of the mixture, these studies provide the foundation for multigene immunization of humans.
CD8(+) T细胞在针对肝细胞内发育的疟原虫的保护性免疫中被认为是关键效应细胞。由于寄生虫的多态性和T细胞反应的基因限制性,一种通过诱导CD8(+) T细胞来预防疟疾的疫苗可能必须包含同一蛋白质或不同蛋白质上的多个表位。为了确定用质粒DNA免疫是否能在灵长类动物中诱导针对多种恶性疟原虫蛋白质的CD8(+) T细胞反应,用编码四种恶性疟原虫蛋白质的DNA质粒混合物或单个质粒对恒河猴进行肌肉注射免疫。在用PfCSP DNA免疫的所有六只猴子、用PfSSP2 DNA免疫的九只中的七只以及用PfExp-1或PfLSA-1 DNA免疫的六只中的五只中,外周血单核细胞在体外再刺激后都有可检测到的抗原特异性细胞毒性T淋巴细胞(CTL)。CTL活性受基因限制且依赖于CD8(+) T细胞。这些研究通过为灵长类动物提供首个证据,即DNA质粒混合物免疫可诱导针对混合物所有成分的CD8(+) T细胞反应,为人类的多基因免疫奠定了基础。